Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 10 |
| 1.1 List of Tables | 5 | 3 |
| 1.2 List of Figures | 8 | 4 |
| 2 Pharmaceuticals &Healthcare, Global, Deal Summary | 12 | 9 |
| 2.1 Pharmaceuticals &Healthcare, Global, Deal Analysis, July 2016 | 12 | 2 |
| 2.2 Pharmaceuticals &Healthcare, Global, Major Deals, July 2016 | 14 | 1 |
| 2.2.1 Teva Pharma Raises USD15 Billion in Public Offering of Notes | 14 | 1 |
| 2.2.2 Teva Pharma Raises USD4.4 Billion in Additional Public Offering of Notes | 15 | 1 |
| 2.2.3 Celgene Enters into Agreement with Jounce Therapeutics | 15 | 1 |
| 2.2.4 Galenica to Acquire Relypsa for USD1.53 Billion in Tender Offer | 16 | 1 |
| 2.2.5 AstraZeneca to Enter into Co-Marketing Agreement with Aspen | 17 | 2 |
| 2.3 Pharmaceuticals &Healthcare, Global, by Type, Number of Deals, July 2016 | 19 | 1 |
| 2.4 Pharmaceuticals &Healthcare, Global, by Type, Deal Values, July 2016 | 20 | 1 |
| 3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type | 21 | 22 |
| 3.1 Pharmaceuticals &Healthcare, Global, M&A, July 2016 | 21 | 1 |
| 3.1.1 Top M&A Deals in July 2016 | 22 | 1 |
| 3.1.2 Pharmaceuticals &Healthcare, Global, M&A Deals by Therapy Area, February 2016 July 2016 | 23 | 1 |
| 3.2 Pharmaceuticals &Healthcare, Global, Equity Offering Deals, July 2016 | 24 | 1 |
| 3.2.1 Top Equity Offering Deals in July 2016 | 25 | 1 |
| 3.2.2 Pharmaceuticals &Healthcare, Global, Equity Offering Deals by Therapy Area, February 2016 July 2016 | 26 | 1 |
| 3.3 Pharmaceuticals &Healthcare, Global, Private Equity and Venture Capital Deals, July 2016 | 27 | 1 |
| 3.3.1 Top PE/VC Deals in July 2016 | 28 | 1 |
| 3.3.2 Pharmaceuticals &Healthcare, Global, PE/VC by Therapy Area, July 2016 | 29 | 1 |
| 3.3.3 Pharmaceuticals &Healthcare, Global, Venture Capital Deals by Stage of Financing, July 2016 | 30 | 1 |
| 3.3.4 Pharmaceuticals &Healthcare, Global, Top Venture Financing Firms, February 2016 July 2016 | 31 | 1 |
| 3.3.5 Pharmaceuticals &Healthcare, Global, Top VC Backed Companies, February 2016 July 2016 | 32 | 1 |
| 3.4 Pharmaceuticals &Healthcare, Global, Partnership Deals, July 2016 | 33 | 2 |
| 3.5 Pharmaceuticals &Healthcare, Global, Partnership Deals by Therapy Area, February 2016 July 2016 | 35 | 1 |
| 3.6 Pharmaceuticals &Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), July 2016 | 36 | 1 |
| 3.6.1 Pharmaceuticals &Healthcare, Global, Top Partnership Deals by Payment Mode, July 2016 | 37 | 1 |
| 3.7 Pharmaceuticals &Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2016 July 2016 | 38 | 2 |
| 3.8 Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, Number Of Deals, February 2016 July 2016 | 40 | 1 |
| 3.9 Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), February 2016 July 2016 | 41 | 1 |
| 3.10 Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, by Upfront &Milestone Payments and Deal Values (US$ m), February 2016 July 2016 | 42 | 1 |
| 4 Pharmaceuticals &Healthcare, Global, Licensing Agreements, July 2016 | 43 | 13 |
| 4.1 Pharmaceuticals &Healthcare, Global, Licensing Agreements, July 2016 | 43 | 2 |
| 4.2 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2016 | 45 | 2 |
| 4.3 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), February 2016 July 2016 | 47 | 2 |
| 4.4 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), February 2016 July 2016 | 49 | 2 |
| 4.5 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), February 2016 July 2016 | 51 | 2 |
| 4.6 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), February 2016 July 2016 | 53 | 1 |
| 4.6.1 Pharmaceuticals &Healthcare, Global, Top Licensing Agreements by Deal Value, July 2016 | 54 | 1 |
| 4.6.2 Pharmaceuticals &Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, July 2016 | 55 | 1 |
| 4.6.3 Pharmaceuticals &Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, July 2016 | 55 | 1 |
| 5 Pharmaceuticals &Healthcare, Global, Deal Summary by Therapy Area | 56 | 21 |
| 5.1 Pharmaceuticals &Healthcare, Global, Oncology Deals, July 2016 | 56 | 1 |
| 5.1.1 Oncology Deals of the Month | 57 | 2 |
| 5.2 Pharmaceuticals &Healthcare, Global, Central Nervous System Deals, July 2016 | 59 | 1 |
| 5.2.1 Central Nervous System Deals of the Month | 60 | 1 |
| 5.3 Pharmaceuticals &Healthcare, Global, Infectious Disease Deals, July 2016 | 61 | 1 |
| 5.3.1 Infectious Diseases Deals of the Month | 62 | 2 |
| 5.4 Pharmaceuticals &Healthcare, Global, Cardiovascular Deals, July 2016 | 64 | 1 |
| 5.4.1 Cardiovascular Deals of the Month | 65 | 2 |
| 5.5 Pharmaceuticals &Healthcare, Global, Immunology Deals, July 2016 | 67 | 1 |
| 5.5.1 Immunology Deals of the Month | 68 | 3 |
| 5.6 Pharmaceuticals &Healthcare, Global, Gastrointestinal Deals, July 2016 | 71 | 1 |
| 5.6.1 Gastrointestinal Deal of the Month | 72 | 3 |
| 5.7 Pharmaceuticals &Healthcare, Global, Metabolic Disorders, Deals, July 2016 | 75 | 1 |
| 5.7.1 Metabolic Disorders Deal of the Month | 76 | 1 |
| 6 Deal Summary by Geography | 77 | 13 |
| 6.1 Pharmaceuticals &Healthcare, North America Deals, July 2016 | 77 | 1 |
| 6.1.1 North America Deals of the Month | 78 | 3 |
| 6.2 Pharmaceuticals &Healthcare, Europe, Deals, July 2016 | 81 | 1 |
| 6.2.1 Europe Deals of the Month | 82 | 2 |
| 6.3 Pharmaceuticals &Healthcare, Asia-Pacific, Regional Deals, July 2016 | 84 | 1 |
| 6.3.1 Asia-Pacific Deals of the Month | 85 | 2 |
| 6.4 Pharmaceuticals &Healthcare, Rest of the World, Deals, July 2016 | 87 | 1 |
| 6.4.1 Rest of the World Deals of the Month | 88 | 2 |
| 7 Pharmaceuticals &Healthcare, Global, Top Financial Advisors | 90 | 4 |
| 7.1 Pharmaceuticals &Healthcare, Global, Top Financial Advisors, M&A, February 2016 July 2016 | 90 | 2 |
| 7.2 Pharmaceuticals &Healthcare, Global, Top Financial Advisors, Equity Offerings, February 2016 July 2016 | 92 | 2 |
| 8 Further Information | 94 | 4 |
| 8.1 Methodology | 94 | 1 |
| 8.2 About GlobalData | 95 | 1 |
| 8.3 Disclosure information | 95 | 1 |
| 8.4 Disclaimer | 96 | 2 |